Correction to: Combination Treatment with an Antibody-Drug Conjugate (A1mcMMAF) Targeting the Oncofetal Glycoprotein 5T4 and Carboplatin Improves Survival in a Xenograft Model of Ovarian Cancer

Y Louise Wan; Puja Sapra; James Bolton; Jia Xin Chua; Lindy G Durrant; Peter L Stern

doi:10.1007/s11523-019-00677-x

Correction to: Combination Treatment with an Antibody-Drug Conjugate (A1mcMMAF) Targeting the Oncofetal Glycoprotein 5T4 and Carboplatin Improves Survival in a Xenograft Model of Ovarian Cancer

Y Louise Wan, Puja Sapra, James Bolton, Jia Xin Chua, Lindy G Durrant, Peter L Stern

Research output: Contribution to journal › Article › peer-review

Abstract

The article Combination Treatment with an Antibody-Drug Conjugate (A1mcMMAF) Targeting the Oncofetal Glycoprotein 5T4 and Carboplatin Improves Survival in a Xenograft Model of Ovarian Cancer, written by Y. Louise Wan, Puja Sapra, James Bolton, Jia Xin Chua, Lindy G. Durrant and Peter L. Stern, was originally published under a CC BY-NC 4.0 license, but has now been made available under a CC BY 4.0 license.

Original language	English
Pages (from-to)	769
Journal	Targeted Oncology
Volume	14
Issue number	6
DOIs	https://doi.org/10.1007/s11523-019-00677-x
Publication status	Published - Dec 2019

Research Beacons, Institutes and Platforms

Manchester Cancer Research Centre

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1007/s11523-019-00677-x

Cite this

@article{52eb3a090eac40cabc6bc3cce0c62022,

title = "Correction to: Combination Treatment with an Antibody-Drug Conjugate (A1mcMMAF) Targeting the Oncofetal Glycoprotein 5T4 and Carboplatin Improves Survival in a Xenograft Model of Ovarian Cancer",

abstract = "The article Combination Treatment with an Antibody-Drug Conjugate (A1mcMMAF) Targeting the Oncofetal Glycoprotein 5T4 and Carboplatin Improves Survival in a Xenograft Model of Ovarian Cancer, written by Y. Louise Wan, Puja Sapra, James Bolton, Jia Xin Chua, Lindy G. Durrant and Peter L. Stern, was originally published under a CC BY-NC 4.0 license, but has now been made available under a CC BY 4.0 license.",

author = "Wan, {Y Louise} and Puja Sapra and James Bolton and Chua, {Jia Xin} and Durrant, {Lindy G} and Stern, {Peter L}",

year = "2019",

month = dec,

doi = "10.1007/s11523-019-00677-x",

language = "English",

volume = "14",

pages = "769",

journal = "Targeted Oncology",

issn = "1776-2596",

publisher = "Springer Paris",

number = "6",

}

TY - JOUR

T1 - Correction to

T2 - Combination Treatment with an Antibody-Drug Conjugate (A1mcMMAF) Targeting the Oncofetal Glycoprotein 5T4 and Carboplatin Improves Survival in a Xenograft Model of Ovarian Cancer

AU - Wan, Y Louise

AU - Sapra, Puja

AU - Bolton, James

AU - Chua, Jia Xin

AU - Durrant, Lindy G

AU - Stern, Peter L

PY - 2019/12

Y1 - 2019/12

N2 - The article Combination Treatment with an Antibody-Drug Conjugate (A1mcMMAF) Targeting the Oncofetal Glycoprotein 5T4 and Carboplatin Improves Survival in a Xenograft Model of Ovarian Cancer, written by Y. Louise Wan, Puja Sapra, James Bolton, Jia Xin Chua, Lindy G. Durrant and Peter L. Stern, was originally published under a CC BY-NC 4.0 license, but has now been made available under a CC BY 4.0 license.

AB - The article Combination Treatment with an Antibody-Drug Conjugate (A1mcMMAF) Targeting the Oncofetal Glycoprotein 5T4 and Carboplatin Improves Survival in a Xenograft Model of Ovarian Cancer, written by Y. Louise Wan, Puja Sapra, James Bolton, Jia Xin Chua, Lindy G. Durrant and Peter L. Stern, was originally published under a CC BY-NC 4.0 license, but has now been made available under a CC BY 4.0 license.

U2 - 10.1007/s11523-019-00677-x

DO - 10.1007/s11523-019-00677-x

M3 - Article

C2 - 31583515

SN - 1776-2596

VL - 14

SP - 769

JO - Targeted Oncology

JF - Targeted Oncology

IS - 6

ER -

Correction to: Combination Treatment with an Antibody-Drug Conjugate (A1mcMMAF) Targeting the Oncofetal Glycoprotein 5T4 and Carboplatin Improves Survival in a Xenograft Model of Ovarian Cancer

Abstract

Research Beacons, Institutes and Platforms

UN SDGs

Access to Document

Fingerprint

Cite this